St. Jude Medicals Neuromodulaton Trial System receives CE Mark
Published By : 05 Jun 2015 |Published By : QYRESEARCH
International medical device company St. Jude Medical Inc. on Thursday announced the approval of CE Mark and the launch of the St. Jude Medical Invisible Trial System in Europe. This is a wireless and application based neuromodulation programming system that leverages the Apple iPad mini and iPod touch technology. Similar to other Apple products, the St. Jude Medical system depends on Bluetooth communication in order to provide a safe, secure, and wireless experience for patients who are testing out spinal cord stimulation for the treatment of chronic pain before actual permanent implantation.
The system has been designed to enhance the usability and comfort of the system in order to help patients evaluate spinal cord stimulation therapy that can alleviate their chronic pain. This will allow them to do so without focusing on probable hurdles such as systems with complex trial controls and programming trial cables.
Dr Stefan Schu at the Sana Clinic in Duisburg, Germany is a senior physician for neuromodulation and a specialist for neurosurgery. He believes that the St. Jude Medical Invisible Trial System will help improve the trial experience for patients significantly. The new system will be familiar and discreet and will need no cables that can be uncomfortable or cause the lead to dislodge. Dr Stefan Schu says that the most important feature of the technology is the therapy in itself. The therapy will allow a unique stimulation mode called Burst that will widen the range of stimulation modes that are available in the trial period. This will help to improve the success rate of the trial for the patients who suffer from chronic pain.
One in every five adults in Europe suffer from chronic pain and over 1.5 billion people all over the world have this condition. Spinal cord stimulation is a therapy that has been proven to manage chronic pain.